[1] Annual report of national ADR monitoring (2018)[J]. China Drug Evaluation(中国药物评价), 2019, 36(6): 476-480. [2] Wu YQ, Liu LL, Li Q, et al.Analysis of adverse drug reactions related to blood system damage in a third-grade a hospital from 2005 to 2013[J]. Anhui Pharmaceuticals(安徽医药), 2015, 19(12): 2435-2437. [3] Former National Ministry of Health. Measures for the reporting and monitoring of adverse drug reactions[S]. Ministry of Health Decree No. 81. 2011. [4] Chen XQ, Jin YY, Tang G.New edition of pharmacology [M]. 17th ed. Beijing: People's Medical Publishing House, 2014: 1-783. [5] Zhang L, Tan L, Lu J.Expert consensus on off-label drug use[J]. Journal of Adverse Drug Reactions(药物不良反应杂志), 2015, 17(2): 101-103 [6] Chinese Journal of Diabetes Expert consensus on safety management of multiple drug use in the elderly[J]. Chinese Journal of Diabetes(中国糖尿病杂志), 2016, 26(9): 705-717. [7] Liu YJ, Wang XF, Miao QL, et al.Analysis of 117 new/severe adverse drug reactions in children[J]. J Pharmacoepidemiology, 2019, 28(9): 585-590. [8] Tao I.Adverse drug reactions and pharmacovigilance in the blood system[J]. J Pharmacoepidemiology(药物流行病学杂志), 2011, 20(3): 148-151. [9] Laine L.Gastrointestinal bleeding withlow-dose aspirin-what's the risk[J] Ali Ment Pharmacol Ther, 2006, 24(6): 897-908. [10] Zhang QX, Gao ZY, Shi DZ, et al.Prospective cohort study on stable antiplatelet therapy for gastrointestinal adverse reactions in coronary heart disease[J]. World Journal of Chinese Medicine(世界中医药), 2013, 8(12): 1400-1403. [11] Venerito M, Kandulski A, Malfertheiner P.Dilemma between gastroprotection and cardiovascular prevention[J]. Dtsch Med Wochenschr, 2010, 135(44): 2193-2198. [12] Wei FX.Cause analysis and preventive care of gastrointestinal adverse reactions in patients treated with antiplatelet therapy[J].Journal of Nursing(护理学杂志), 2010, 25(5): 29-31. [13] Li YB, Wang SY, Wang CG.Analysis of 221 cases of adverse drug reactions in our hospital[J]. Exploration of Rational Drug Use in China(中国合理用药探索), 2019, 16(8): 19196-19198. [14] Chen WF, Huang XY.Investigation and analysis of off-label use of antitumor drugs and adjuvant drugs[J]. Straits Pharmacy, 2017, 29(8): 225-228. [15] Huang L, Shen XL, Chen L, et al.Correct understanding and effective regulation of off-label drug use behavior[J]. Chinese Journal of Hospital Pharmacy, 2009, 29(11): 949-951. |